Harrow Health Inc (NASDAQ:HROW)
| 8.64 Delayed Data As of 3:59pm ET |  +0.10 / +1.17%Today’s Change | 5.40 Today|||52-Week Range 12.99 | 0.00% Year-to-Date |
Largest transactions by value over
| Name | Type | Date | Shares traded | Share price | Transaction value | Since transaction |
|---|---|---|---|---|---|---|
Baum Mark L Chief Executive Officer |  Sale | 1/20/2022 | 71,406 | $8.33 | $594.8K | +2.04% |
Opaleye Management Inc |  Buy | 8/19/2021 | 50,000 | $8.44 | $422.0K | +1.07% |
Baum Mark L Chief Executive Officer | Buy | 1/20/2022 | 125,000 | $2.40 | $300.0K | +2.04% |
Saharek John P | Sale | 2/19/2022 | 25,923 | $7.87 | $204.0K | +2.53% |
Opaleye Management Inc | Buy | 4/12/2022 | 25,000 | $6.75 | $168.8K | +26.30% |
Boll Andrew R Chief Financial Officer | Sale | 2/19/2022 | 20,605 | $7.87 | $162.2K | +2.53% |
Lindstrom Richard L Director | Sale | 9/15/2021 | 14,160 | $9.09 | $128.7K | -6.08% |
Opaleye Management Inc | Buy | 4/13/2022 | 10,000 | $6.76 | $67.6K | +25.37% |
Lindstrom Richard L Director | Sale | 9/16/2021 | 5,840 | $9.02 | $52.7K | -7.51% |
Lindstrom Richard L Director | Sale | 9/24/2021 | 3,900 | $10.04 | $39.2K | -10.43% |
Page of 2